IL-6 could play an important role in these processes because, in addition to being involved in the acute phase of inflammatory response, its concentrations significantly increased in those conditions characterized by chronic subclinical inflammation, such as metabolic disorders, overweight and cardiovascular diseases. The gene discussed is IL6; the disease is metabolic disease.